Centene said its senior management team plans to reaffirm its 2024 full-year adjusted diluted EPS guidance of greater than $6.80 when it meets with investors. The company said this is consistent with the guidance it provided on September 4, 2024.

1. 01

   Centene said its senior management team plans to reaffirm its 2024 full-year adjusted diluted EPS guidance of greater than $6.80 when it meets with investors. The company said this is consistent with the guidance it provided on September 4, 2024.

2. 02

   The company said it will reiterate the shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4 and projects Q3 adjusted diluted EPS of $1.31 to $1.41. It said the remainder of the 2024 full-year adjusted diluted EPS is expected to be realized in Q4.

3. 03

   Centene said its senior management team plans to reiterate that it remains encouraged by the progress it has made in improving its stars program performance in Medicare Advantage.

4. 04

   The company said it presents non-GAAP measures that exclude amortization of acquired intangible assets, acquisition and divestiture related expenses, and other items. It said it is unable to provide a reconciliation of its 2024 adjusted diluted EPS outlook to the most directly comparable GAAP measure because of the difficulty of predicting the timing and amounts of various items.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.